Person

Sean E. Harper

Formerly EVP, Research & Development, Amgen

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$6.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • AMGN
    Amgen
    EVP, Research & Development
    2016 or earlier – last filing Jul 2018

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 16, 2018AMGNSale1,525$195.71$298K
Jun 12, 2018AMGNSale1,525$184.27$281K
May 14, 2018AMGNSale1,525$174.10$266K
Apr 12, 2018AMGNSale1,525$172.68$263K
Mar 16, 2018AMGNSale1,525$189.75$289K
Feb 14, 2018AMGNSale1,525$174.18$266K
Jan 16, 2018AMGNSale1,525$185.62$283K
Dec 12, 2017AMGNSale1,525$176.83$270K
Nov 13, 2017AMGNSale1,525$171.58$262K
Oct 9, 2017AMGNSale1,525$185.95$284K
Apr 29, 2016AMGNSale21,875$157.99$3.5M

SEC reporting-owner ID (CIK) 1541946 · all filings on EDGAR